Search
for
Sort by
Research 91–120 of 1000+
- 019 Herpes simplex virus infection in pemphigus patients: a prospective study
- Chinese SLE Treatment and Research Group (CSTAR) Registry: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Calcineurin/Nuclear Factor of Activated T-Cell Pathway in Cutaneous Squamous Cell Carcinoma
- GP85 The irish experience in paediatric parry romberg syndrome- a case series highlighting management and surgical outcomes
- Medical Treatment of Alopecia
- Hair Disorders
- Discoid Lupus Erythematosus
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Benign Cutaneous Eruptions After Transplantation
- Cicatricial Alopecias
- Alopecia fibrosante frontal
- Connective Tissue Disorders
- A Case of 300 Pound Weight Loss, Malabsorption, Malnutrition and Protein Losing Enteropathy Due to Systemic Lupus Erythematosis of the Small Intestine
- Cytostatics and immunosuppressive drugs
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- The role of lymphocytes in the development and treatment of alopecia areata
- Alopecia Areata
- Alopecia areata: Part 2: treatment.
- Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.
- TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- A Case Study on Exploring Immune Dysregulation in Alopecia Areata - Mechanisms and Treatments Outcomes
- A Case Report On Alopecia Areata – A Comprehensive Clinical Analysis
- Baricitinib (Olumiant)
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- A novel therapeutic paradigm for patients with extensive alopecia areata
- [Successful treatment of "steroid-immunosuppressant resistant" polymyositis with immunoadsorption].